BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32827583)

  • 1. The emerging role of miRNA clusters in breast cancer progression.
    Kandettu A; Radhakrishnan R; Chakrabarty S; Sriharikrishnaa S; Kabekkodu SP
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188413. PubMed ID: 32827583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small nucleolar RNA and its potential role in breast cancer - A comprehensive review.
    Dsouza VL; Adiga D; Sriharikrishnaa S; Suresh PS; Chatterjee A; Kabekkodu SP
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188501. PubMed ID: 33400969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA co-expression patterns unravel the relevance of extra cellular matrix and immunity in breast cancer.
    Dugo M; Huang X; Iorio MV; Cataldo A; Tagliabue E; Daidone MG; Wu J; Orlandi R
    Breast; 2018 Jun; 39():46-52. PubMed ID: 29597130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cluster miRNAs and cancer: Diagnostic, prognostic and therapeutic opportunities.
    Kabekkodu SP; Shukla V; Varghese VK; Adiga D; Vethil Jishnu P; Chakrabarty S; Satyamoorthy K
    Wiley Interdiscip Rev RNA; 2020 Mar; 11(2):e1563. PubMed ID: 31436881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
    Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRNAs as potential markers for breast cancer and regulators of tumorigenesis and progression (Review).
    Mu H; Zhang W; Qiu Y; Tao T; Wu H; Chen Z; Xu G
    Int J Oncol; 2021 May; 58(5):. PubMed ID: 33760165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.
    Nogales-Cadenas R; Cai Y; Lin JR; Zhang Q; Zhang W; Montagna C; Zhang ZD
    Breast Cancer Res; 2016 Jul; 18(1):75. PubMed ID: 27449149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinatorial epigenetic regulation of non-coding RNAs has profound effects on oncogenic pathways in breast cancer subtypes.
    Xu J; Wang Z; Li S; Chen J; Zhang J; Jiang C; Zhao Z; Li J; Li Y; Li X
    Brief Bioinform; 2018 Jan; 19(1):52-64. PubMed ID: 27742663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clustered miRNAs and their role in biological functions and diseases.
    Kabekkodu SP; Shukla V; Varghese VK; D' Souza J; Chakrabarty S; Satyamoorthy K
    Biol Rev Camb Philos Soc; 2018 Nov; 93(4):1955-1986. PubMed ID: 29797774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aryl hydrocarbon receptor-microRNA-212/132 axis in human breast cancer suppresses metastasis by targeting SOX4.
    Hanieh H
    Mol Cancer; 2015 Sep; 14():172. PubMed ID: 26377202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New emerging roles of microRNAs in breast cancer.
    Mandujano-Tinoco EA; García-Venzor A; Melendez-Zajgla J; Maldonado V
    Breast Cancer Res Treat; 2018 Sep; 171(2):247-259. PubMed ID: 29948402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs in breast cancer pathogenesis.
    Götte M
    Minerva Ginecol; 2010 Dec; 62(6):559-71. PubMed ID: 21079577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of prognostic biomarkers for breast cancer based on miRNA and mRNA co-expression network.
    Yao Y; Liu R; Gao C; Zhang T; Qi L; Liu G; Zhang W; Wang X; Li J; Li J; Sun C
    J Cell Biochem; 2019 Sep; 120(9):15378-15388. PubMed ID: 31037764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive review on the functional role of miRNA clusters in cervical cancer.
    Sriharikrishnaa S; John FE; Bairy M; Shetty S; Suresh PS; Kabekkodu SP
    Epigenomics; 2024 Apr; 16(7):493-511. PubMed ID: 38511231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential of miRNAs for diagnosis, treatment and monitoring of breast cancer.
    Bertoli G; Cava C; Castiglioni I
    Scand J Clin Lab Invest Suppl; 2016; 245():S34-9. PubMed ID: 27435502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variations in tumor-suppressor miRNA-encoding genes and their target genes: focus on breast cancer development and possible therapeutic strategies.
    Chhichholiya Y; Singh HV; Singh S; Munshi A
    Clin Transl Oncol; 2024 Jan; 26(1):1-15. PubMed ID: 37093457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of miRNA expression profiles in breast cancer using biclustering.
    Fiannaca A; La Rosa M; La Paglia L; Rizzo R; Urso A
    BMC Bioinformatics; 2015; 16 Suppl 4(Suppl 4):S7. PubMed ID: 25734576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases.
    Xiong DD; Lv J; Wei KL; Feng ZB; Chen JT; Liu KC; Chen G; Luo DZ
    Oncol Rep; 2017 Jun; 37(6):3297-3304. PubMed ID: 28440475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deregulated miRNA clusters in ovarian cancer: Imperative implications in personalized medicine.
    Kandettu A; Adiga D; Devi V; Suresh PS; Chakrabarty S; Radhakrishnan R; Kabekkodu SP
    Genes Dis; 2022 Nov; 9(6):1443-1465. PubMed ID: 36157483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candidate miRNAs in human breast cancer biomarkers: a systematic review.
    Adhami M; Haghdoost AA; Sadeghi B; Malekpour Afshar R
    Breast Cancer; 2018 Mar; 25(2):198-205. PubMed ID: 29101635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.